Drug Abuse as a Cause, Correlate, or Consequence of Criminal Justice Related Health Disparities among African Americans (R01)
The summary for the Drug Abuse as a Cause, Correlate, or Consequence of Criminal Justice Related Health Disparities among African Americans (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Drug Abuse as a Cause, Correlate, or Consequence of Criminal Justice Related Health Disparities among African Americans (R01): The purpose of this Program Announcement is to encourage epidemiologic, prevention, treatment, and services research on criminal justice related health disparities among African Americans as it relates to drug abuse and addiction. Health disparities among African Americans are a major public health concern in the United States. In particular, while African Americans represent about 12 percent of the general population, they are over-represented in the criminal justice system. This announcement is aimed at fostering new drug abuse and addiction research on criminal justice related health and disease outcomes among African Americans. Specifically, it seeks to understand risk factors and pathways between drug abuse and criminal justice involvement, and to determine the extent to which criminal justice involvement and HIV/AIDS risk are interlinked or compounded by drug abuse and addiction.
|Federal Grant Title:||Drug Abuse as a Cause, Correlate, or Consequence of Criminal Justice Related Health Disparities among African Americans (R01)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-06-068|
|Type of Funding:||Grant|
|CFDA Descriptions:||Drug Abuse Research Programs|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple dates, see announcement.|
|Posted Date:||Nov 10, 2005|
|Creation Date:||Dec 07, 2006|
|Archive Date:||Feb 03, 2007|
|Total Program Funding:||$3,000,000|
|Maximum Federal Grant Award:||$350,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:||10|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Special district governments State governments Private institutions of higher education
- Additional Information on Eligibility
- Eligible agencies of the Federal government are eligible to apply
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
- Similar Government Grants
- • Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
- • New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Tria...
- • New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Tr...
- • NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
- • Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical T...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
- • New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...